Provectus Presentation at Cancer Immunotherapy Conference

This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring :

• Craig Dees, PhD, Chief Executive Officer, Provectus Pharmaceuticals Inc., (PVCT.OB)

Safe Harbor Statement :

Except for historical information, the statements made in the presentation are forward-looking statements involving significant risks and uncertainties. These risks and uncertainties, including those related to the future financial position and business strategy of Provectus, are detailed in the Company’s filings with the U.S. Securities and Exchange Commission.

Related Videos:

1. Biovest International Presentation at Cancer Immunotherapy Conference
2. Dendreon Presentation at Cancer Immunotherapy Conference
3. ImmunoCellular Therapeutics Presentation at Cancer Immunotherapy Conference
4. Celldex Presentation at Cancer Immunotherapy Conference
5. Northwest Biotherapeutics Presentation at Cancer Immunotherapy Conference
6. BioSante Presentation at Cancer Immunotherapy Conference
7. Vaccinogen Presentation at Cancer Immunotherapy Conference
8. Inovio Presentation at Cancer Immunotherapy Conference
9. Bavarian Presentation at Cancer Immunotherapy Conference
10. Argos Therapeutics Presentation at Cancer Immunotherapy Conference